$BRZH
Breeze Holdings Acquisition Corp. Stock $brzh

$brzh Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 10-Q Financial Statement

#000121390023086204 Filed on November 13, 2023

Income Statement

Concept	2023 Q4	2023 Q3
Revenue	$0.00	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$506.7K	$370.0K
YoY Change	-28.88%	-29.34%
Operating Profit		-$370.0K
YoY Change		-29.35%
Interest Expense	$167.6K	$166.5K
YoY Change		20385.49%
% of Operating Profit
Other Income/Expense, Net	$1.016M	-$679.7K
YoY Change	-400.0%	-134.21%
Pretax Income	$676.4K	-$1.050M
YoY Change	-164.36%	-171.75%
Income Tax	-$15.63K	$26.94K
% Of Pretax Income	-2.31%
Net Earnings	$692.0K	-$1.077M
YoY Change	-165.95%	-173.78%
Net Earnings / Revenue
Basic Earnings Per Share		-$0.25
Diluted Earnings Per Share	$0.16	-$0.25
COMMON SHARES
Basic Shares Outstanding	4.299M shares	4.320M shares
Diluted Shares Outstanding		4.319M shares

Balance Sheet

Concept	2023 Q4	2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$4.230K	$200.0K
YoY Change	-70.06%	249900.0%
Cash & Equivalents	$4.228K	$181.7K
Short-Term Investments
Other Short-Term Assets	$261.9K	$100.0K
YoY Change	38.9%	-60.47%
Inventory
Prepaid Expenses	$149.0K	$149.1K
Receivables
Other Receivables
Total Short-Term Assets	$266.1K	$349.4K
YoY Change	31.3%	38.08%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$12.98M	$12.70M
YoY Change	-26.81%	-27.65%
Other Assets
YoY Change
Total Long-Term Assets	$12.98M	$12.69M
YoY Change	-26.81%	-27.72%
TOTAL ASSETS
Total Short-Term Assets	$266.1K	$349.4K
Total Long-Term Assets	$12.98M	$12.69M
Total Assets	$13.24M	$13.04M
YoY Change	-26.15%	-26.78%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$206.6K	$200.0K
YoY Change	206.13%	-77.54%
Accrued Expenses	$56.27K	$100.0K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change		-100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$8.077M	$7.548M
YoY Change	45.53%	60.17%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$2.200M	$3.200M
YoY Change	85.71%	278.14%
Total Long-Term Liabilities	$2.200M	$3.200M
YoY Change	85.71%	278.14%
TOTAL LIABILITIES
Total Short-Term Liabilities	$8.077M	$7.548M
Total Long-Term Liabilities	$2.200M	$3.200M
Total Liabilities	$10.28M	$10.76M
YoY Change	52.59%	93.63%
SHAREHOLDERS EQUITY
Retained Earnings	-$9.682M	-$10.25M
YoY Change	48.22%	93.25%
Common Stock	$315.00	$315.00
YoY Change	0.0%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$9.682M	-$10.25M
YoY Change
Total Liabilities & Shareholders Equity	$13.24M	$13.04M
YoY Change	-26.15%	-26.78%

Cashflow Statement

Concept	2023 Q4	2023 Q3
OPERATING ACTIVITIES
Net Income	$692.0K	-$1.077M
YoY Change	-165.95%	-173.78%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	-$688.4K	-$290.0K
YoY Change	-49.54%	-79.01%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	-$121.7K	$320.0K
YoY Change	-36.49%	-99.69%
Cash From Investing Activities	-$121.7K	$320.0K
YoY Change	-36.49%	-99.69%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	632.7K	140.0K
YoY Change	-59.7%	-100.14%
NET CHANGE
Cash From Operating Activities	-688.4K	-290.0K
Cash From Investing Activities	-121.7K	320.0K
Cash From Financing Activities	632.7K	140.0K
Net Change In Cash	-177.5K	170.0K
YoY Change	-1363.06%	-1876.38%
FREE CASH FLOW
Cash From Operating Activities	-$688.4K	-$290.0K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	14129	usd
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q3	brez	Business Combination Right Convertible Share Of Common Stock Conversion Ratio BusinessCombinationRightConvertibleShareOfCommonStockConversionRatio	0.05	pure
	dei	Entity Address State Or Province EntityAddressStateOrProvince	TX
CY2023Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
	dei	Entity Central Index Key EntityCentralIndexKey	0001817640
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-09-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-39718
	dei	Entity Registrant Name EntityRegistrantName	BREEZE HOLDINGS ACQUISITION CORP.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	85-1849315
	dei	Entity Address Address Line1 EntityAddressAddressLine1	955 W. John Carpenter Freeway
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 100-929
	dei	Entity Address City Or Town EntityAddressCityOrTown	Irving
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	75039
	dei	City Area Code CityAreaCode	(619)
	dei	Local Phone Number LocalPhoneNumber	500-7747
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	true
CY2023Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	4299276	shares
CY2023Q3	us-gaap	Cash Cash	181681	usd
CY2022Q4	us-gaap	Cash Cash	14129	usd
CY2023Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	149052	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	160503	usd
CY2023Q3	brez	Prepayment Franchise Taxes Current PrepaymentFranchiseTaxesCurrent		usd
CY2022Q4	brez	Prepayment Franchise Taxes Current PrepaymentFranchiseTaxesCurrent	10000	usd
CY2023Q3	us-gaap	Assets Current AssetsCurrent	349405	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	202705	usd
CY2023Q3	us-gaap	Assets Held In Trust Noncurrent AssetsHeldInTrustNoncurrent	12688162	usd
CY2022Q4	us-gaap	Assets Held In Trust Noncurrent AssetsHeldInTrustNoncurrent	17730969	usd
CY2023Q3	us-gaap	Assets Assets	13037567	usd
CY2022Q4	us-gaap	Assets Assets	17933674	usd
CY2023Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	210422	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	67500	usd
CY2023Q3	brez	Franchise Tax Payable FranchiseTaxPayable	79648	usd
CY2022Q4	brez	Franchise Tax Payable FranchiseTaxPayable		usd
CY2023Q3	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	56270	usd
CY2022Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent		usd
CY2023Q3	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	3939	usd
CY2022Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	2089	usd
CY2023Q3	us-gaap	Liabilities Current LiabilitiesCurrent	7547853	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	5550530	usd
CY2023Q3	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	3215750	usd
CY2022Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	1184750	usd
CY2023Q3	us-gaap	Liabilities Liabilities	10763603	usd
CY2022Q4	us-gaap	Liabilities Liabilities	6735280	usd
CY2023Q3	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	1159276	shares
CY2022Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	1690196	shares
CY2023Q3	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	12525978	usd
CY2022Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	17730156	usd
CY2023Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	26939	usd
CY2022Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3715	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	33797	usd
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2023Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q3	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	3140000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	3140000	shares
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	3140000	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	3140000	shares
CY2023Q3	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	1159276	shares
CY2022Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	1690196	shares
CY2023Q3	us-gaap	Common Stock Value CommonStockValue	315	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	315	usd
CY2023Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital		usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital		usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-10252329	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-6532077	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	-10252014	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-6531762	usd
CY2023Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	13037567	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	17933674	usd
CY2023Q3	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	369952	usd
CY2022Q3	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	523629	usd
	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	1563416	usd
	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	1610619	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-369952	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-523629	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1563416	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1610619	usd
CY2023Q3	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	166547	usd
CY2022Q3	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	813	usd
	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	387058	usd
	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	813	usd
CY2023Q3	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments		usd
CY2022Q3	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	69760	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments		usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	188904	usd
CY2023Q3	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	846250	usd
CY2022Q3	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-1916000	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	2031000	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-6262250	usd
CY2023Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-679703	usd
CY2022Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1986573	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1643942	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	6451967	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1049655	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1462944	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-3207358	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	4841348	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3715	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-1076594	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	1459229	usd
	us-gaap	Net Income Loss NetIncomeLoss	-3241155	usd
	us-gaap	Net Income Loss NetIncomeLoss	4837633	usd
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	4318640	shares
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4318640	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	7338471	shares
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	7338471	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	4471096	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4471096	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	10798286	shares
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.25
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.25
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.2
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.72
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.45
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.45
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-6531762	usd
CY2023Q1	brez	Common Stock Accretion To Redemption Value CommonStockAccretionToRedemptionValue	-173001	usd
CY2023Q1	brez	Equity Adjustment Related To Excise Taxes Payable EquityAdjustmentRelatedToExciseTaxesPayable	53959	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-654261	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-7412983	usd
CY2023Q2	brez	Common Stock Accretion To Redemption Value CommonStockAccretionToRedemptionValue	-123951	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-1510300	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-9047234	usd
CY2023Q3	brez	Common Stock Accretion To Redemption Value CommonStockAccretionToRedemptionValue	-125875	usd
CY2023Q3	brez	Equity Adjustment Related To Excise Taxes Payable EquityAdjustmentRelatedToExciseTaxesPayable	2311	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-1076594	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	-10252014	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-8919146	usd
CY2022Q1	brez	Common Stock Accretion To Redemption Value CommonStockAccretionToRedemptionValue	-1150000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	2567790	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	-7501356	usd
CY2022Q2	brez	Common Stock Accretion To Redemption Value CommonStockAccretionToRedemptionValue	-14213	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	810614	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	-6704955	usd
CY2022Q3	brez	Common Stock Accretion To Redemption Value CommonStockAccretionToRedemptionValue	-59157	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	1459229	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	-5304883	usd
	us-gaap	Profit Loss ProfitLoss	-3241155	usd
	us-gaap	Profit Loss ProfitLoss	4837633	usd
	brez	Interest And Unrealized Gain Loss On Investments InterestAndUnrealizedGainLossOnInvestments	387058	usd
	brez	Interest And Unrealized Gain Loss On Investments InterestAndUnrealizedGainLossOnInvestments	189717	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	2031000	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-6262250	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-20852	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	120098	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	158682	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	292167	usd
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	1850	usd
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	3715	usd
	brez	Increase Decrease In Franchise Taxes Payable IncreaseDecreaseInFranchiseTaxesPayable	79648	usd
	brez	Increase Decrease In Franchise Taxes Payable IncreaseDecreaseInFranchiseTaxesPayable	-208706	usd
	brez	Increase Decrease In Current Portion Of Long Term Liabilities IncreaseDecreaseInCurrentPortionOfLongTermLiabilities		usd
	brez	Increase Decrease In Current Portion Of Long Term Liabilities IncreaseDecreaseInCurrentPortionOfLongTermLiabilities	-11293	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1336181	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1658549	usd
	us-gaap	Payments To Acquire Trust Preferred Investments PaymentsToAcquireTrustPreferredInvestments	406790	usd
	us-gaap	Payments To Acquire Trust Preferred Investments PaymentsToAcquireTrustPreferredInvestments	1209157	usd
	brez	Cash Withdrawn From Trust Account To Redeeming Shareholders CashWithdrawnFromTrustAccountToRedeemingShareholders	5627006	usd
	brez	Cash Withdrawn From Trust Account To Redeeming Shareholders CashWithdrawnFromTrustAccountToRedeemingShareholders	101545684	usd
	brez	Cash Withdrawn From Trust Account To Pay Franchise And Income Taxes CashWithdrawnFromTrustAccountToPayFranchiseAndIncomeTaxes	209650	usd
	brez	Cash Withdrawn From Trust Account To Pay Franchise And Income Taxes CashWithdrawnFromTrustAccountToPayFranchiseAndIncomeTaxes	231247	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	5429866	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	100567774	usd
	brez	Proceeds From Short Term Working Capital Loan Related Party ProceedsFromShortTermWorkingCapitalLoanRelatedParty	1335400	usd
	brez	Proceeds From Short Term Working Capital Loan Related Party ProceedsFromShortTermWorkingCapitalLoanRelatedParty	1421975	usd
	brez	Proceeds From Promissory Note Related Party ProceedsFromPromissoryNoteRelatedParty	365473	usd
	brez	Proceeds From Promissory Note Related Party ProceedsFromPromissoryNoteRelatedParty	1209157	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	5627006	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	101545684	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-3926133	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-98914552	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	167552	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-5327	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	5403	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	181681	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	76	usd
	brez	Non Cash Excise Taxes Payable NonCashExciseTaxesPayable	56270	usd
	brez	Non Cash Excise Taxes Payable NonCashExciseTaxesPayable		usd
	brez	Accretion Of Common Stocks Subject To Redemption Value AccretionOfCommonStocksSubjectToRedemptionValue	422827	usd
	brez	Accretion Of Common Stocks Subject To Redemption Value AccretionOfCommonStocksSubjectToRedemptionValue	1223370	usd
CY2020Q4	brez	Sale Of Private Placement Warrants SaleOfPrivatePlacementWarrants	5425000	shares
CY2020Q4	brez	Class Of Warrant Or Right Issue Price Of Warrants Or Rights Per Share ClassOfWarrantOrRightIssuePriceOfWarrantsOrRightsPerShare	1
CY2023Q3	brez	Aggregate Fair Market Value Of Acquisition Threshold As Percentage Of Assets Held In Trust Account AggregateFairMarketValueOfAcquisitionThresholdAsPercentageOfAssetsHeldInTrustAccount	0.80	pure
	brez	Minimum Voting Interest To Be Owned Or Acquired To Complete Business Combination MinimumVotingInterestToBeOwnedOrAcquiredToCompleteBusinessCombination	0.50	pure
CY2023Q3	us-gaap	Temporary Equity Redemption Price Per Share TemporaryEquityRedemptionPricePerShare	10.15
CY2023Q3	brez	Business Combination Minimum Threshold Limit Of Net Intangible Assets Required BusinessCombinationMinimumThresholdLimitOfNetIntangibleAssetsRequired	5000001	usd
	brez	Restriction On Public Share Redemption In Case Of Stockholder Approval Of Business Combination RestrictionOnPublicShareRedemptionInCaseOfStockholderApprovalOfBusinessCombination	0.10	pure
	brez	Business Combination Incomplete Percentage Of Stock Redemption BusinessCombinationIncompletePercentageOfStockRedemption	1	pure
CY2022Q2	us-gaap	Temporary Equity Redemption Price Per Share TemporaryEquityRedemptionPricePerShare	10.35
CY2022Q2	us-gaap	Stock Redeemed Or Called During Period Shares StockRedeemedOrCalledDuringPeriodShares	6732987	shares
CY2022Q2	us-gaap	Stock Redeemed Or Called During Period Value StockRedeemedOrCalledDuringPeriodValue	69700628	usd
CY2022Q2	brez	Cash Withdrawn From Trust Account CashWithdrawnFromTrustAccount	109000	usd
CY2022Q3	us-gaap	Temporary Equity Redemption Price Per Share TemporaryEquityRedemptionPricePerShare	10.35
CY2022Q3	us-gaap	Stock Redeemed Or Called During Period Shares StockRedeemedOrCalledDuringPeriodShares	3076817	shares
CY2022Q3	us-gaap	Stock Redeemed Or Called During Period Value StockRedeemedOrCalledDuringPeriodValue	31845056	usd
CY2022Q3	brez	Cash Withdrawn From Trust Account CashWithdrawnFromTrustAccount	122247	usd
CY2022Q3	us-gaap	Temporary Equity Par Or Stated Value Per Share TemporaryEquityParOrStatedValuePerShare	0.035
CY2022Q3	us-gaap	Temporary Equity Value Excluding Additional Paid In Capital TemporaryEquityValueExcludingAdditionalPaidInCapital	59157	usd
CY2022Q3	us-gaap	Temporary Equity Value Excluding Additional Paid In Capital TemporaryEquityValueExcludingAdditionalPaidInCapital	59157	usd
	brez	Business Combination Completion Date Of Acquisition BusinessCombinationCompletionDateOfAcquisition	2024-06-26
CY2023Q3	brez	Business Combination Incomplete Maximum Dissolution Expenses To Be Paid BusinessCombinationIncompleteMaximumDissolutionExpensesToBePaid	100000	usd
	brez	Assets Remaining Available For Distribution Per Share Maximum AssetsRemainingAvailableForDistributionPerShareMaximum	10.81
CY2022Q4	brez	Business Combination Expected To Close BusinessCombinationExpectedToClose	quarter of 2024
CY2023Q3	us-gaap	Cash Cash	181681	usd
CY2023Q3	brez	Working Capital WorkingCapital	7058591	usd
CY2020Q4	brez	Proceeds From Sale Of Founder Shares ProceedsFromSaleOfFounderShares	25000	usd
CY2020Q4	brez	Proceeds From Unsecured And Non Interest Bearing Promissory Notes ProceedsFromUnsecuredAndNonInterestBearingPromissoryNotes	300000	usd
CY2023Q1	us-gaap	Stock Redeemed Or Called During Period Shares StockRedeemedOrCalledDuringPeriodShares	509712	shares
CY2023Q1	us-gaap	Stock Redeemed Or Called During Period Value StockRedeemedOrCalledDuringPeriodValue	5400000	usd
CY2023Q3	us-gaap	Stock Redeemed Or Called During Period Shares StockRedeemedOrCalledDuringPeriodShares	21208	shares
CY2023Q3	us-gaap	Stock Redeemed Or Called During Period Value StockRedeemedOrCalledDuringPeriodValue	231000	usd
CY2023Q1	brez	Percentage Of Excise Tax On Redemption Amount Paid PercentageOfExciseTaxOnRedemptionAmountPaid	0.01	pure
CY2023Q3	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	56270	usd
CY2023Q1	brez	Percentage Of Excise Tax Liability Shares Redeemed PercentageOfExciseTaxLiabilitySharesRedeemed	0.01	pure
	us-gaap	Use Of Estimates UseOfEstimates	<p class="highlightCont" style="margin: 0px; text-indent: 0px; font-style: italic; font-size: 10pt; font-family: 'Times New Roman'; text-transform: none; font-variant: normal;"><span style="font-weight: bold; line-height: inherit; font-size: 10pt;">Use of estimates</span></p> <p class="highlightCont" style="margin: 0pt; text-indent: 0pt; font-style: italic; font-size: 10pt; font-family: 'Times New Roman'; text-transform: none; font-variant: normal;"><br/></p> <p class="highlightCont" style="margin: 0pt; text-indent: 0pt; font-size: 10pt; font-family: 'Times New Roman'; font-weight: normal; font-style: normal; text-transform: none; font-variant: normal;"><span style="font-size: 10pt; line-height: inherit;">The preparation of the condensed consolidated financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.</span></p> <p class="highlightCont" style="margin: 0pt; text-indent: 0pt; font-size: 10pt; font-family: 'Times New Roman'; font-weight: normal; font-style: normal; text-transform: none; font-variant: normal;"><br/></p> <p class="highlightCont" style="margin: 0pt; text-indent: 0pt; font-size: 10pt; font-family: 'Times New Roman'; font-weight: normal; font-style: normal; text-transform: none; font-variant: normal;"><span style="font-size: 10pt; line-height: inherit;">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to <span>one</span> or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</span></p>
CY2023Q3	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0	usd
CY2022Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0	usd
CY2022Q2	us-gaap	Stock Redeemed Or Called During Period Shares StockRedeemedOrCalledDuringPeriodShares	6732987	shares
CY2022Q3	us-gaap	Temporary Equity Redemption Price Per Share TemporaryEquityRedemptionPricePerShare	10.35
CY2022Q3	us-gaap	Stock Redeemed Or Called During Period Shares StockRedeemedOrCalledDuringPeriodShares	3076817	shares
CY2022Q3	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	1690196	shares
CY2023Q1	us-gaap	Temporary Equity Redemption Price Per Share TemporaryEquityRedemptionPricePerShare	10.56
CY2023Q1	us-gaap	Stock Redeemed Or Called During Period Shares StockRedeemedOrCalledDuringPeriodShares	509712	shares
CY2023Q3	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	1159276	shares
CY2023Q3	us-gaap	Temporary Equity Redemption Price Per Share TemporaryEquityRedemptionPricePerShare	10.77
CY2023Q3	us-gaap	Stock Redeemed Or Called During Period Shares StockRedeemedOrCalledDuringPeriodShares	21208	shares
CY2023Q3	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	1159276	shares
CY2023Q3	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue	125875	usd
CY2023Q3	us-gaap	Stock Redeemed Or Called During Period Value StockRedeemedOrCalledDuringPeriodValue	231076	usd
CY2023Q3	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	12525978	usd
	brez	Offering Costs Incurred In Connection With Issuance Of Common Stock OfferingCostsIncurredInConnectionWithIssuanceOfCommonStock	3704282	usd
CY2023Q3	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2023Q3	us-gaap	Income Tax Examination Penalties And Interest Accrued IncomeTaxExaminationPenaltiesAndInterestAccrued	0	usd
CY2022Q4	us-gaap	Income Tax Examination Penalties And Interest Accrued IncomeTaxExaminationPenaltiesAndInterestAccrued	0	usd
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	0	shares
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	0	shares
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-1076594	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	1459229	usd
	us-gaap	Net Income Loss NetIncomeLoss	-3241155	usd
	us-gaap	Net Income Loss NetIncomeLoss	4837633	usd
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	4318640	shares
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4318640	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	7338471	shares
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	7338471	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	4471096	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4471096	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	10798286	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	10798286	shares
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.25
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.25
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.2
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.2
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.72
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.72
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.45
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.45
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p class="highlightCont" style="margin: 0pt; text-indent: 0pt; font-style: italic; font-size: 10pt; font-family: 'Times New Roman'; text-transform: none; font-variant: normal; line-height: 1.2;"><span style="font-weight: bold; line-height: inherit; font-size: 10pt;">Concentration of credit risk</span></p> <p class="highlightCont" style="margin: 0pt; text-indent: 0pt; font-style: italic; font-size: 10pt; font-family: 'Times New Roman'; text-transform: none; font-variant: normal; line-height: 1.2;"><br/></p> <p class="highlightCont" style="margin: 0pt; text-indent: 0pt; font-size: 10pt; font-family: 'Times New Roman'; font-weight: normal; font-style: normal; text-transform: none; font-variant: normal; line-height: 1.2;"><span style="font-size: 10pt; line-height: inherit;">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times may exceed the FDIC coverage of $250,000. The Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.</span></p>
	us-gaap	Concentration Risk Credit Risk Financial Instrument Maximum Exposure ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure	250000	usd
	brez	Percentage Of Advisor Cash Fee On Gross Proceeds Of Initial Public Offering PercentageOfAdvisorCashFeeOnGrossProceedsOfInitialPublicOffering	0.0275	pure
	brez	Cash Fee For Advisory Services Upon Consummation Of Business Combination CashFeeForAdvisoryServicesUponConsummationOfBusinessCombination	3162500	usd
CY2023Q3	brez	Number Of Fractional Shares Issued Upon Exercise Of Public Warrant NumberOfFractionalSharesIssuedUponExerciseOfPublicWarrant	0	shares
	brez	Warrants Exercisable Period After Completion Of Business Combination WarrantsExercisablePeriodAfterCompletionOfBusinessCombination	P30D
	brez	Warrants Exercisable Period From Closing Of Initial Public Offering WarrantsExercisablePeriodFromClosingOfInitialPublicOffering	P12M
	brez	Warrant Expiration Period After Completion Of Business Combination Or Earlier Upon Redemption Or Liquidation WarrantExpirationPeriodAfterCompletionOfBusinessCombinationOrEarlierUponRedemptionOrLiquidation	P5Y
CY2023Q3	brez	Class Of Warrant Or Right Exercisable ClassOfWarrantOrRightExercisable	0	shares
CY2023Q3	brez	Class Of Warrant Or Right Redemption Price ClassOfWarrantOrRightRedemptionPrice	0.01
	brez	Minimum Period Of Prior Written Notice Of Redemption Of Warrants MinimumPeriodOfPriorWrittenNoticeOfRedemptionOfWarrants	P30D
CY2023Q3	brez	Minimum Price Per Share Required For Redemption Of Warrants MinimumPricePerShareRequiredForRedemptionOfWarrants	18
	brez	Warrants Redemption Covenant Threshold Trading Days WarrantsRedemptionCovenantThresholdTradingDays	P20D
	brez	Warrants Redemption Covenant Threshold Consecutive Trading Days WarrantsRedemptionCovenantThresholdConsecutiveTradingDays	P30D
CY2023Q3	brez	Maximum Effective Issue Price To Closing Of Business Combination MaximumEffectiveIssuePriceToClosingOfBusinessCombination	9.2
CY2023Q3	brez	Minimum Percentage Of Equity Proceeds From Issuances MinimumPercentageOfEquityProceedsFromIssuances	0.60	pure
	brez	Number Of Trading Days Prior On Consummates Business Combination NumberOfTradingDaysPriorOnConsummatesBusinessCombination	P20D
CY2023Q3	brez	Maximum Effective Issue Price To Closing Of Business Combination MaximumEffectiveIssuePriceToClosingOfBusinessCombination	9.2
CY2023Q3	brez	Percentage Of Exercise Price Of Warrants Adjusted Equal To Higher Of Market Value And Issued Price PercentageOfExercisePriceOfWarrantsAdjustedEqualToHigherOfMarketValueAndIssuedPrice	1.15	pure
CY2023Q3	brez	Minimum Price Per Share Required For Redemption Of Warrants MinimumPricePerShareRequiredForRedemptionOfWarrants	18
	brez	Percentage Of Redemption Triggered Price Of Warrants Adjusted Equal To Higher Of Market Value And Issued Price PercentageOfRedemptionTriggeredPriceOfWarrantsAdjustedEqualToHigherOfMarketValueAndIssuedPrice	1.80	pure
	brez	Warrants Will Not Be Transferable Assignable Or Saleable Number Of Period After Completion Of Business Combination WarrantsWillNotBeTransferableAssignableOrSaleableNumberOfPeriodAfterCompletionOfBusinessCombination	P30D
CY2023Q3	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	5425000	shares
CY2023Q3	brez	Class Of Warrant Or Right Issue Price Of Warrants Or Rights Per Share ClassOfWarrantOrRightIssuePriceOfWarrantsOrRightsPerShare	1
CY2023Q3	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	5425000	usd
CY2023Q3	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight	1	shares
CY2023Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	11.5
	brez	Warrants Will Not Be Transferable Assignable Or Saleable Number Of Period After Completion Of Business Combination WarrantsWillNotBeTransferableAssignableOrSaleableNumberOfPeriodAfterCompletionOfBusinessCombination	P30D
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	2031000	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-6262250	usd
CY2023Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2023Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
	us-gaap	Common Stock Voting Rights CommonStockVotingRights	Holders of common stock are entitled to one vote for each share.
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	3140000	shares
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	3140000	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	3140000	shares
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	3140000	shares
CY2023Q3	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	1159276	shares
CY2022Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	1690196	shares
CY2022	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Out Of Level3 FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3	0	usd
CY2022	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Into Level3 FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3	0	usd
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Into Level3 FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3	0	usd
CY2022	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3	0	usd
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3	0	usd
CY2022	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3	0	usd
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3	0	usd
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Out Of Level3 FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3	0	usd
CY2021Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	7108500	usd
CY2022Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease	3500000	usd
CY2022Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	3608500	usd
CY2022Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease	846250	usd
CY2022Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	2762250	usd
CY2022Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease	1916000	usd
CY2022Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	846250	usd
CY2022Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	1184750	usd
CY2023Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease	169250	usd
CY2023Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	1015500	usd
CY2023Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease	-1354000	usd
CY2023Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	2369500	usd
CY2023Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease	-846250	usd
CY2023Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	3215750	usd
CY2023Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.0257	pure
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.011	pure
CY2022Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.0025	pure
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.0008	pure
	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure

Files In Submission

Name	View Source	Status
brez-20230930_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
0001213900-23-086204-index-headers.html	Edgar Link	pending
0001213900-23-086204-index.html	Edgar Link	pending
0001213900-23-086204.txt	Edgar Link	pending
0001213900-23-086204-xbrl.zip	Edgar Link	pending
brez-20230930.htm	Edgar Link	pending
brez-20230930.xsd	Edgar Link	pending
ex311_1.htm	Edgar Link	pending
ex321_2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
brez-20230930_def.xml	Edgar Link	unprocessable
brez-20230930_lab.xml	Edgar Link	unprocessable
brez-20230930_htm.xml	Edgar Link	completed
brez-20230930_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$BRZH
Breeze Holdings Acquisition Corp. Stock $brzh

2023 Q4 Form 10-Q Financial Statement

#000121390023086204 Filed on November 13, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BRZH Breeze Holdings Acquisition Corp. Stock $brzh

2023 Q4 Form 10-Q Financial Statement

#000121390023086204 Filed on November 13, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BRZH
Breeze Holdings Acquisition Corp. Stock $brzh